Intraperitoneal radioactive chromic phosphate (P32) in the treatment of ovarian cancer.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002857:Chromium / Q000008:administration & dosage / Q000627:therapeutic use*; D017608:Chromium Compounds; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D010710:Phosphates / Q000008:administration & dosage / Q000627:therapeutic use*; D010761:Phosphorus Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D011379:Prognosis
D000970:Antineoplastic Agents; D017608:Chromium Compounds; D010710:Phosphates; D010761:Phosphorus Radioisotopes; D002857:Chromium; C509369:chromic phosphate